Jonathan Harrington

BACKGROUND: Long COVID (LC) affects approximately 10% of SARS-CoV-2 positive patients, causing significant workforce loss and an annual economic cost of $743 billion in the United States. Previous studies have suggested an association between long COVID and alterations in the gut microbiome…

BACKGROUND: Immune activation by immune checkpoint inhibitors (ICI) has shown promise in the treatment of diverse cancer types at the cost of different immune-related adverse events (irAEs)…